Pri-Med Chicago

Chicago, IL | July 18-19, 2019

McCormick Place

Disclosures

The following financial relationships have been disclosed by faculty:   

Financial Disclosures

John E. Anderson, MD
AstraZeneca, Advisory Board; AstraZeneca, Consultant; AstraZeneca, Speakers Bureau; Boehringer Ingelheim Pharmaceuticals, Inc., Advisory Board; Janssen Scientific Affairs, LLC, Advisory Board; Janssen Scientific Affairs, LLC, Consultant; Janssen Scientific Affairs, LLC, Speakers Bureau; Lilly USA, LLC, Advisory Board; Lilly USA, LLC, Consultant; Lilly USA, LLC, Speakers Bureau; MannKind Corporation, Advisory Board; Merck & Co., Inc., Advisory Board; Novo Nordisk Inc., Advisory Board; Novo Nordisk Inc., Consultant; Novo Nordisk Inc., Speakers Bureau; Sanofi US, Advisory Board; Sanofi US, Consultant; Sanofi US, Speakers Bureau
Michael Angarone, DO
Allergan Pharmaceuticals, Speakers Bureau
M. Susan Burke, MD, FACP
No financial disclosures
Katherine Carroll, MD
No financial disclosures
Ty J. Gluckman, MD, FACC, FAHA
AbbVie Inc., Consultant; Teva Pharmaceuticals, Consultant
Richard J. Hamill, MD
No financial disclosures
John Leahy, MD
Merck & Co., Inc., Advisory Board; Novo Nordisk Inc., Advisory Board
Lee A. Lindquist, MD, MPH, MBA
No financial disclosures
Neil Skolnik, MD
amgen, Consulting; AstraZeneca, Consulting; AstraZeneca, Membership on Advisory Committees or Review Panels; AstraZeneca, Speaking and Teaching; Lilly, Consulting; Succampo, Membership on Advisory Committees or Review Panels; Teva, Consulting
Gerald W. Smetana, MD
No financial disclosures
Charles Vega, MD, FAAFP
No financial disclosures
Shirah Vollmer, MD
No financial disclosures

Other Disclosures

Pamela Kushner, MD, FAAFP (Reviewer):  Advisory Board and Speaker's Bureau for AstraZeneca, GlaxoSmithKline, and Janssen Pharmaceuticals, Inc.; Consulting Fee and Services Provided for Promotional Purposes for AstraZeneca and Janssen Pharmaceuticals.

All other non-faculty contributors involved in the planning, development, editing and review of the content have disclosed no relevant financial relationships.